retatrutide obesity triple hormone receptor agonist Media Centre Retatrutide | GLP-1R/GIPR/GCGR ligand |

Their lucrative value in part reflects the fact that many studies are showing them to have therapeutic promise for several indications beyond type-2 diabetes and obesity (Manalac Dec 2024)

These include bitter melon, fenugreek, gymnema sylvestre, berberine, alpha-lipoic acid, and cinnamon in supplemental doses

The Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month on any PlexusDx protocol) maps 49 genes and 58 variants across 14 health pathways including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response so the prescribing clinician knows whether a faster titration, a slower one, or a tirzepatide-first approach better fits your biology

doi:10.1038/s41467-022-28683-0 216

Naunyn Schmiedeberg Arch Pharmacol